Based on the hypothesis that BCR activation may depend on somatic mutations of the BCR and related pathways we have performed a complete mutational screening of 301 selected genes associated with BCR signaling and related pathways, such as NFkB, using massive parallel sequencing technology in 10 CLL cases. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.